DLD Asset Management, LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 113 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.3%.

Quarter-by-quarter ownership
DLD Asset Management, LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$837,000
-96.8%
82,200
-93.9%
0.06%
-98.5%
Q1 2017$26,015,000
+2904.0%
1,350,306
+2298.8%
4.18%
+1370.1%
Q4 2016$866,00056,2900.28%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders